Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in Recurrent High-grade Gliomas
NCT00045708Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2002
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in high-grade glioma (HGG), sponsored by National Cancer Institute. Started Oct 2002; status: completed.
02
Drugs
ixabepilone
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT00045708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00045708.